Pamela M Marcus

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Tracking and tracing of participants in two large cancer screening trials
    Pamela M Marcus
    National Cancer Institute, Bethesda, MD 20892 7344, USA
    Contemp Clin Trials 33:601-5. 2012
  2. pmc Recruitment methods employed in the National Lung Screening Trial
    Pamela M Marcus
    Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
    J Med Screen 19:94-102. 2012
  3. pmc The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death
    Pamela M Marcus
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892 7354, USA
    Contemp Clin Trials 32:834-40. 2011
  4. doi request reprint The impact of a primetime cancer storyline: from individual knowledge and behavioral intentions to policy-level changes
    Pamela M Marcus
    US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 6130 Executive Blvd Suite, 3131, Bethesda, MD 20892 7354, USA
    J Cancer Educ 25:484-9. 2010
  5. pmc Atrophic gastritis and the risk of incident colorectal cancer
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
    Cancer Causes Control 21:163-70. 2010
  6. pmc Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA
    BMC Cancer 9:84. 2009
  7. pmc Lung cancer screening practices of primary care physicians: results from a national survey
    Carrie N Klabunde
    Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Ann Fam Med 10:102-10. 2012
  8. pmc Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Clin Gastroenterol Hepatol 7:192-7. 2009
  9. ncbi request reprint Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer
    John K Gohagan
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, EPN 3064, Bethesda, MD 20892, USA
    Lung Cancer 47:9-15. 2005
  10. doi request reprint Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8574, USA
    Clin Trials 7:69-77. 2010

Detail Information

Publications25

  1. pmc Tracking and tracing of participants in two large cancer screening trials
    Pamela M Marcus
    National Cancer Institute, Bethesda, MD 20892 7344, USA
    Contemp Clin Trials 33:601-5. 2012
    ..Centers developed methods to track participants and trace them when necessary. We describe the methods used to keep track of participants and trace them when lost, and the extent to which each method was used...
  2. pmc Recruitment methods employed in the National Lung Screening Trial
    Pamela M Marcus
    Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
    J Med Screen 19:94-102. 2012
    ..To report participant recruitment experiences in a large, US randomized controlled trial (RCT) of lung cancer screening, with the aim of providing information that may be of use to researchers who wish to conduct similar future studies...
  3. pmc The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death
    Pamela M Marcus
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892 7354, USA
    Contemp Clin Trials 32:834-40. 2011
    ..We describe the National Lung Screening Trial's (NLST's) death review approach, the Endpoint Verification Process (EVP), which strives to minimize errors in assignment of cause of death due to lung cancer...
  4. doi request reprint The impact of a primetime cancer storyline: from individual knowledge and behavioral intentions to policy-level changes
    Pamela M Marcus
    US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 6130 Executive Blvd Suite, 3131, Bethesda, MD 20892 7354, USA
    J Cancer Educ 25:484-9. 2010
    ..Entertainment education can have a positive impact on cancer knowledge and can contribute to policy-level decisions...
  5. pmc Atrophic gastritis and the risk of incident colorectal cancer
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
    Cancer Causes Control 21:163-70. 2010
    ..We prospectively examined the association of atrophic gastritis, a pre-malignant condition for gastric cancer and long-term sequelae common to many exposure factors, and the risk of incident CRC...
  6. pmc Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA
    BMC Cancer 9:84. 2009
    ..We therefore evaluated known risk factors for breast cancer in a cancer screening trial that does not have breast cancer as a study endpoint but is large enough to provide numerous analytic opportunities for breast cancer...
  7. pmc Lung cancer screening practices of primary care physicians: results from a national survey
    Carrie N Klabunde
    Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Ann Fam Med 10:102-10. 2012
    ..In this study, we examined the lung cancer screening practices of US primary care physicians and characteristics of those who order lung cancer screening tests...
  8. pmc Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Clin Gastroenterol Hepatol 7:192-7. 2009
    ..Prospective information on the risk of adenoma recurrence associated with hyperplastic polyps is limited. We sought to investigate whether the coexistence of hyperplastic polyps with adenomas increases the risk of adenoma recurrence...
  9. ncbi request reprint Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer
    John K Gohagan
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, EPN 3064, Bethesda, MD 20892, USA
    Lung Cancer 47:9-15. 2005
    ..A total of 16 stage III-IV cancers were observed in the LDCT arm versus nine in the CXR arm. The LSS has established the feasibility of a RCT comparing annual spiral CT to chest X-ray for lung cancer screening...
  10. doi request reprint Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8574, USA
    Clin Trials 7:69-77. 2010
    ..Often in randomized controlled trials of cancer screening, cause of death is determined by a mortality review committee. However, little is known regarding how findings from mortality review compare to those from death certificates alone...
  11. pmc Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey
    V Paul Doria-Rose
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 21:1049-59. 2012
    ..The National Lung Screening Trial (NLST), which showed a 20% reduction in lung cancer mortality among those randomized to receive low-dose computed tomography (LDCT), will likely lead to increased screening use...
  12. ncbi request reprint Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Paul F Pinsky
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    J Natl Med Assoc 100:291-8. 2008
    ..Here, we report the experience of enrolling ethnic minorities in a large cancer screening trial...
  13. pmc Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy
    Adeyinka O Laiyemo
    Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, USA
    Cancer Epidemiol 36:395-9. 2012
    ....
  14. pmc Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Cancer 115:5007-17. 2009
    ..However, these findings were based on incomplete follow-up, and each trial on its own was underpowered to detect a modest mortality benefit...
  15. doi request reprint Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial
    Jennifer M Croswell
    National Institutes of Health, National Cancer Institute, Bethesda, and Information Management Services, Rockville, Maryland 20892, USA
    Ann Intern Med 152:505-12, W176-80. 2010
    ..However, screening exposes healthy persons to potential harms, and cumulative false-positive rates for low-dose CT have never been formally reported...
  16. ncbi request reprint Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review
    Lawrence S Engel
    Occupational Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7240, USA
    Am J Epidemiol 156:95-109. 2002
    ..45, 95% CI: -0.03, 0.93). These results indicate that, among populations studied to date, GSTM1 null status is associated with a modest increase in the risk of bladder cancer...
  17. ncbi request reprint Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Biometry Research Group, Divisionof Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann Intern Med 148:419-26. 2008
    ..Lack of confidence in postpolypectomy surveillance guidelines may be a factor in the observed low adherence rates among providers...
  18. pmc New models for large prospective studies: is there a better way?
    Teri A Manolio
    Office of Population Genomics, National Human Genome Research Institute, Bethesda, Maryland, USA
    Am J Epidemiol 175:859-66. 2012
    ..Whether and how these approaches may be transportable to the United States remain to be explored, but their success in studies such as UK Biobank makes a compelling case for such explorations to begin...
  19. pmc Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Cancer Epidemiol 33:368-73. 2009
    ..We hypothesized that low SPGI level may be associated with an increased risk of pancreatic cancer and be a useful biomarker for the disease...
  20. pmc Cancer screening trials: nuts and bolts
    Philip C Prorok
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Semin Oncol 37:216-23. 2010
    ..Throughout the presentation we illustrate topics with examples from completed or ongoing RCTs, including the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and the National Lung Screening Trial (NLST)...
  21. pmc Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7354, USA
    Lung Cancer 63:295-300. 2009
    ..In these data, death certificates were sufficiently sensitive and specific such that their use did not result in a meaningful change to mortality-based outcomes...
  22. ncbi request reprint Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis
    Pamela M Marcus
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20895 7354, USA
    J Natl Cancer Inst 98:748-56. 2006
    ..Because that excess could instead have resulted from short follow-up time, we investigated this possibility by conducting long-term lung cancer incidence follow-up...
  23. pmc U.S. primary care physicians' lung cancer screening beliefs and recommendations
    Carrie N Klabunde
    Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Am J Prev Med 39:411-20. 2010
    ..Nevertheless, lung cancer screening tests are available in the U.S., and primary care physicians (PCPs) may have a role in recommending them to patients...
  24. pmc Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Clin Gastroenterol Hepatol 7:562-7; quiz 497. 2009
    ..We examined the use and yield of surveillance colonoscopy among participants in the Polyp Prevention Trial (PPT) after the 4-year dietary intervention trial ended...
  25. ncbi request reprint Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen
    Paul F Pinsky
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cancer 103:157-63. 2005
    ....